Literature DB >> 10908045

Validation and reproducibility of measurement of 5-HT1A receptor parameters with [carbonyl-11C]WAY-100635 in humans: comparison of arterial and reference tisssue input functions.

R V Parsey1, M Slifstein, D R Hwang, A Abi-Dargham, N Simpson, O Mawlawi, N N Guo, R Van Heertum, J J Mann, M Laruelle.   

Abstract

Serotonin 5-HT(1A) receptors are implicated in the pathophysiology of neuropsychiatric conditions. The goal of this study was to evaluate methods to derive 5-HT(1A) receptor parameters in the human brain with positron emission tomography (PET) and [carbonyl-(11)C]WAY 100635. Five healthy volunteer subjects were studied twice. Three methods of analysis were used to derive the binding potential (BP), and the specific to nonspecific equilibrium partition coefficient (k3/k4). Two methods, kinetic analysis based on a three compartment model and graphical analysis, used the arterial plasma time-activity curves as the input function to derive BP and k3/k4. A third method, the simplified reference tissue model (SRTM), derived the input function from uptake data of a region of reference, the cerebellum, and provided only k3/k4. All methods provided estimates of regional 5-HT(1A) receptor parameters that were highly correlated. Results were consistent with the known distribution of 5-HT(1A) receptors in the human brain. Compared with kinetic BP, graphical analysis slightly underestimated BP, and this phenomenon was mostly apparent in small size-high noise regions. Compared with kinetic k3/k4, the reference tissue method underestimated k3/k4 and the underestimation was apparent primarily in regions with high receptor density. Derivation of BP by both kinetic and graphical analysis was highly reliable, with an intraclass correlation coefficient (ICC) of 0.84 +/- 0.14 (mean +/- SD of 15 regions) and 0.84 +/- 0.19, respectively. In contrast, the reliability of k3/k4 was lower, with ICC of 0.53 +/- 0.28, 0.47 +/- 0.28, and 0.55 +/- 0.29 for kinetic, graphical, and reference tissue methods, respectively. In conclusion, derivation of BP by kinetic analysis using the arterial plasma input function appeared as the method of choice because of its higher test-retest reproducibility, lower vulnerability to experimental noise, and absence of bias.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10908045     DOI: 10.1097/00004647-200007000-00011

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  82 in total

1.  In vivo and in vitro validation of reference tissue models for the mGluR(5) ligand [(11)C]ABP688.

Authors:  David Elmenhorst; Luciano Minuzzi; Antonio Aliaga; Jared Rowley; Gassan Massarweh; Mirko Diksic; Andreas Bauer; Pedro Rosa-Neto
Journal:  J Cereb Blood Flow Metab       Date:  2010-06-09       Impact factor: 6.200

2.  In vivo positron emission tomography imaging with [¹¹C]ABP688: binding variability and specificity for the metabotropic glutamate receptor subtype 5 in baboons.

Authors:  Christine DeLorenzo; Matthew S Milak; Kathleen G Brennan; J S Dileep Kumar; J John Mann; Ramin V Parsey
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-01-29       Impact factor: 9.236

3.  Visualization and quantification of neurokinin-1 (NK1) receptors in the human brain.

Authors:  Jarmo Hietala; Mikko J Nyman; Olli Eskola; Aki Laakso; Tove Grönroos; Vesa Oikonen; Jörgen Bergman; Merja Haaparanta; Sarita Forsback; Päivi Marjamäki; Pertti Lehikoinen; Michael Goldberg; Donald Burns; Terence Hamill; Wai-Si Eng; Alexandre Coimbra; Richard Hargreaves; Olof Solin
Journal:  Mol Imaging Biol       Date:  2005 Jul-Aug       Impact factor: 3.488

4.  5-HT₁A receptor binding is increased after recovery from bulimia nervosa compared to control women and is associated with behavioral inhibition in both groups.

Authors:  Ursula F Bailer; Cinnamon S Bloss; Guido K Frank; Julie C Price; Carolyn C Meltzer; Chester A Mathis; Mark A Geyer; Angela Wagner; Carl R Becker; Nicholas J Schork; Walter H Kaye
Journal:  Int J Eat Disord       Date:  2010-09-24       Impact factor: 4.861

5.  In vivo quantification of human serotonin 1A receptor using 11C-CUMI-101, an agonist PET radiotracer.

Authors:  Matthew S Milak; Christine DeLorenzo; Francesca Zanderigo; Jaya Prabhakaran; J S Dileep Kumar; Vattoly J Majo; J John Mann; Ramin V Parsey
Journal:  J Nucl Med       Date:  2010-12       Impact factor: 10.057

6.  Noise contamination from PET blood sampling pump: Effects on structural MRI image quality in simultaneous PET/MR studies.

Authors:  Elizabeth Bartlett; Christine DeLorenzo; Ramin Parsey; Chuan Huang
Journal:  Med Phys       Date:  2017-12-22       Impact factor: 4.071

7.  Synthesis and Evaluation of Pyridyloxypyridyl Indole Carboxamides as Potential PET Imaging Agents for 5-HT2C Receptors.

Authors:  Fanxing Zeng; Jonathon A Nye; Ronald J Voll; Leonard Howell; Mark M Goodman
Journal:  ACS Med Chem Lett       Date:  2018-02-05       Impact factor: 4.345

8.  Autoradiographic evaluation of [3H]CUMI-101, a novel, selective 5-HT1AR ligand in human and baboon brain.

Authors:  J S Dileep Kumar; Ramin V Parsey; Suham A Kassir; Vattoly J Majo; Matthew S Milak; Jaya Prabhakaran; Norman R Simpson; Mark D Underwood; J John Mann; Victoria Arango
Journal:  Brain Res       Date:  2013-02-27       Impact factor: 3.252

9.  Positron emission tomography quantification of serotonin transporter in suicide attempters with major depressive disorder.

Authors:  Jeffrey M Miller; Natalie Hesselgrave; R Todd Ogden; Gregory M Sullivan; Maria A Oquendo; J John Mann; Ramin V Parsey
Journal:  Biol Psychiatry       Date:  2013-03-01       Impact factor: 13.382

10.  Lack of association between the serotonin transporter and serotonin 1A receptor: an in vivo PET imaging study in healthy adults.

Authors:  Michael Strupp-Levitsky; Jeffrey M Miller; Harry Rubin-Falcone; Francesca Zanderigo; Matthew S Milak; Gregory Sullivan; R Todd Ogden; Maria A Oquendo; Christine DeLorenzo; Norman Simpson; Ramin V Parsey; J John Mann
Journal:  Psychiatry Res Neuroimaging       Date:  2016-08-08       Impact factor: 2.376

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.